Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells

Molecular Oncology

Volumn 9, Issue 8, 2015, Pages 1612-1625

  Catalano, Myriam ^a,e   D'Alessandro, Giuseppina ^a,e   Lepore, Francesca ^b   Corazzari, Marco ^b,c   Caldarola, Sara ^b   Valacca, Cristina ^d   Faienza, Fiorella ^b   Esposito, Vincenzo ^e   Limatola, Cristina ^a,e   Cecconi, Francesco ^b,d,f   Di Bartolomeo, Sabrina ^b,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^e IRCCS NEUROMED   (Italy)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Autophagy; Cell migration; EMT; Glioma

Indexed keywords

BECLIN 1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHEMOKINE; CHLOROQUINE; CYCLOHEXIMIDE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NERVE CELL ADHESION MOLECULE; RAPAMYCIN; RNA; TORIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; 1-(4-(4-PROPIONYLPIPERAZIN-1-YL)-3-(TRIFLUOROMETHYL)PHENYL)-9-(QUINOLIN-3-YL)BENZO(H)(1,6)NAPHTHYRIDIN-2(1H)-ONE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; LEUPEPTIN; NAPHTHYRIDINE DERIVATIVE; SERUM-FREE MEDIUM;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING; ANIMAL; CELL MOTION; DRUG EFFECTS; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; SERUM-FREE MEDIUM; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ANIMALS; AUTOPHAGY; CELL LINE, TUMOR; CELL MOVEMENT; CHLOROQUINE; CULTURE MEDIA, SERUM-FREE; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOBLASTOMA; HUMANS; LEUPEPTINS; MICE; NAPHTHYRIDINES; NEOPLASM INVASIVENESS; UP-REGULATION;

EID: 84942199396     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.04.016     Document Type: Article

References (48)

1. Acloque H., Adams M.S., Fishwick K., Bronner-fraser M., Nieto M.A. Review series epithelial-mesenchymal transitions: the importance of changing cell state in development and disease 2009, 119(6).
2. Amaravadi R.K., Lippincott-Schwartz J., Yin X.-M., Weiss W.A., Takebe N., Timmer W., et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
3. Boya P., Reggiori F., Codogno P. Emerging regulation and functions of autophagy. Nat. Cell Biol. 2013, 15:713-720. [Internet], Available from:. http://www.ncbi.nlm.nih.gov/pubmed/23817233.
4. Camand E., Peglion F., Osmani N., Sanson M., Etienne-Manneville S. N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration. J. Cell Sci. 2012 Feb 15, 125(Pt 4):844-857. [Internet], [cited 2014 May 1]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/22275437.
5. Candolfi M., Curtin J.F., Nichols W.S., Muhammad A.G., King G.D., Pluhar G.E., et al. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J. Neurooncol. 2007, 85:133-148.
6. Choi K.S. Autophagy and cancer. Exp. Mol. Med. 2012, 109.
7. Choi A.M.K., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013 Mar 14, 368(7):651-662. [Internet], [cited 2014 Apr 29]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/23406030.
8. Cianfanelli V., Fuoco C., Lorente M., Salazar M., Quondamatteo F., Gherardini P.F., et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat. Cell Biol. 2014, 17(1).
9. De Craene B., Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 2013, 13:97-110. [Internet], Available from:. http://www.ncbi.nlm.nih.gov/pubmed/23344542.
10. Di Bartolomeo S., Nazio F., Cecconi F. The role of autophagy during development in higher eukaryotes. Traffic Oct 2010, 11(10):1280-1289. [Internet], [cited 2014 Apr 30]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/20633243.
11. Di Bartolomeo S., Corazzari M., Nazio F., Oliverio S., Lisi G., Antonioli M., et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J. Cell Biol. 4 Oct 2010, 191(1):155-168. [Internet], [cited 2014 May 2]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2953445%26tool=pmcentrez%26rendertype=abstract.
12. Dufour M., Dormond-Meuwly A., Demartines N., Dormond O. Targeting the mammalian target of rapamycin (mTOR) in cancer therapy: lessons from past and future perspectives. Cancers (Basel) 2011 Jan, 3(2):2478-2500. [Internet], [cited 2014 Apr 28]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3757428%26tool=pmcentrez%26rendertype=abstract.
13. Galanis E., Buckner J.C., Maurer M.J., Kreisberg J.I., Ballman K., Boni J., et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J. Clin. Oncol. 2005 Aug 10, 23(23):5294-5304. [Internet], [cited 2014 May 15]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/15998902.
14. Galavotti S., Bartesaghi S., Faccenda D., Shaked-Rabi M., Sanzone S., McEvoy A., et al. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013 Feb 7, 32(6):699-712. [Internet]. Nature Publishing Group, [cited 2014 May 2]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/22525272.
15. Gheldof A., Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog. Mol. Biol. Transl. Sci. 2013, 116:317-336.
16. Guillamo J.S., Doz F., Delattre J.Y. Brain stem gliomas. Curr. Opin. Neurol. 2001, 14:711-715.
17. Gulhati P., Bowen K.A., Liu J., Stevens P.D., Rychahou P.G., Chen M., et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011 May 1, 71(9):3246-3256. [Internet], [cited 2014 May 5]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3085654%26tool=pmcentrez%26rendertype=abstract.
18. Guo J.Y., Xia B., White E. Autophagy-mediated tumor promotion. Cell 2013, 1216-1219.
19. Han S.P., Kim J.H., Han M.E., Sim H.E., Kim K.S., Yoon S., et al. SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell. Mol. Neurobiol. 2011, 31:489-496.
20. Hemavathy K., Ashraf S.I., Ip Y.T. Snail/Slug family of repressors: slowly going into the fast lane of development and cancer. Gene 2000, 1-12.
21. Johnson E., Theisen C.S., Johnson K.R., Wheelock M.J. R-cadherin influences cell motility via Rho family GTPases. J. Biol. Chem. 2004 Jul 23, 279(30):31041-31049. [Internet], [cited 2014 May 15]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/15143071.
22. Kimmelman A.C. The dynamic nature of autophagy in cancer. Genes Dev. 2011, 1999-2010.
23. Lander R., Nordin K., LaBonne C. The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. J. Cell Biol. 2011 Jul 11, 194(1):17-25. [Internet], [cited 2014 Apr 30]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3135407%26tool=pmcentrez%26rendertype=abstract.
24. Lee J.K., Joo K.M., Lee J., Yoon Y., Nam D.H. Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling. Onco Targets Ther. 2014, 7:1933-1944.
25. Lewis-Tuffin L.J., Rodriguez F., Giannini C., Scheithauer B., Necela B.M., Sarkaria J.N., et al. Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 2010 Jan, 5(10):e13665. [Internet], [cited 2014 May 15]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2965143%26tool=pmcentrez%26rendertype=abstract.
26. Liao H., Huang Y., Guo B., Liang B., Liu X., Ou H., et al. Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma 2015, 5(1):125-139.
27. Lv Q., Wang W., Xue J., Hua F., Mu R., Lin H., et al. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res. 2012 Jul 1, 72(13):3238-3250. [Internet], [cited 2014 May 15]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/22719072.
28. Macintosh R.L., Timpson P., Thorburn J., Anderson K.I., Thorburn A., Ryan K.M. Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 2012, 11:2022-2029.
29. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 728-741.
30. Nakaya Y., Sheng G. EMT in developmental morphogenesis. Cancer Lett. 2013, 9-15.
31. Nazio F., Strappazzon F., Antonioli M., Bielli P., Cianfanelli V., Bordi M., et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat. Cell Biol. 2013, 15:406-416. [Internet], Available from:. http://www.ncbi.nlm.nih.gov/pubmed/23524951.
32. Nghiemphu P.L., Lai A., Green R.M., Reardon D.A., Cloughesy T. A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas. J. Neurooncol. 2012 Nov, 110(2):245-250. [Internet], [cited 2014 May 15]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3472078%26tool=pmcentrez%26rendertype=abstract.
33. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008, 68:3645-3654.
34. Palumbo S., Tini P., Toscano M., Allavena G., Angeletti F., Manai F., et al. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells. J. Cell. Physiol. 2014, 229:1863-1873. [Internet]. http://www.ncbi.nlm.nih.gov/pubmed/24691646.
35. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
36. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112(12):1809-1820.
37. Rubin J.B., Kung A.L., Klein R.S., Chan J.A., Sun Y., Schmidt K., et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. U. S. A. 2003 Nov 11, 100(23):13513-13518. [Internet], Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=263845%26tool=pmcentrez%26rendertype=abstract.
38. Sciaccaluga M., D'Alessandro G., Pagani F., Ferrara G., Lopez N., Warr T., et al. Functional cross talk between CXCR4 and PDGFR on glioblastoma cells is essential for migration. PLoS One 2013 Jan, 8(9):e73426. [Internet], [cited 2014 May 13]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3759384%26tool=pmcentrez%26rendertype=abstract.
39. Stemmer V., de Craene B., Berx G., Behrens J. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008 Aug 28, 27(37):5075-5080. [Internet], [cited 2014 Apr 30]. Available from:. http://www.ncbi.nlm.nih.gov/pubmed/18469861.
40. Szatmári T., Lumniczky K., Désaknai S., Trajcevski S., Hídvégi E.J., Hamada H., et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci. 2006, 97:546-553.
41. Thompson E.W., Williams E.D. EMT and MET in carcinoma - clinical observations, regulatory pathways and new models. Clin. Exp. Metastasis 2008, 25:591-592.
42. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012 May 3, 485(7396):109-113. [Internet]. Nature Publishing Group, [cited 2014 Apr 30]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3347774%26tool=pmcentrez%26rendertype=abstract.
43. Tuloup-Minguez V., Hamaï A., Greffard A., Nicolas V., Codogno P., Botti J. Autophagy modulates cell migration and β1 integrin membrane recycling. Cell Cycle 2013 Oct 15, 12(20):3317-3328. [Internet], Available from:. http://www.ncbi.nlm.nih.gov/pubmed/24036548.
44. Viñas-Castells R., Beltran M., Valls G., Gómez I., García J.M., Montserrat-Sentís B., et al. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J. Biol. Chem. 2010 Mar 5, 285(6):3794-3805. [Internet], [cited 2014 Apr 30]. Available from:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2823521%26tool=pmcentrez%26rendertype=abstract.
45. Wheelock M.J., Johnson K.R. Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol. 2003, 19:207-235.
46. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 401-410.
47. Yook J.I., Li X.-Y., Ota I., Fearon E.R., Weiss S.J. Wnt-dependent regulation of the E-cadherin repressor snail. J. Biol. Chem. 2005, 280:11740-11748.
48. Zhou B.P., Hung M.-C. Wnt, hedgehog and snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis. Cell Cycle 2005, 4:772-776.